MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-29-0007787
J B K Sun Pharma India Private Limited
J B K Sun Pharma India Private Limited - chemicals in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹15.1 Lakh
▼ 17% YoY
Net loss · FY 2024
₹1.71 Lakh
Net margin -11.3%
EBITDA · FY 2024
-₹29,461
EBITDA margin -2%
Authorised capital
₹7 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.05 Lakh
Secured borrowings
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings
About J B K Sun Pharma India Private Limited
Data last updated:
J B K Sun Pharma India Private Limited is a private limited company based in Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 14 May 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2002PTC115355. Its GSTIN is 09AABCJ3322Q1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Singhal and Meera Rani Singhal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 3747/Agali No – 2 Kanhiya Nagar Tri Nagar, Delhi, India – 110035.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.1 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹1.71 Lakh (net margin -11.3%) and EBITDA of -₹29,461 (EBITDA margin -2%). Revenue has declined at a compounded annual rate (CAGR) of 6% over five years.
As per MCA filings, the company has open charges of ₹5.05 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
J B K Sun Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0007787). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231DL2002PTC115355
Registration Number 115355
Incorporation Date 14 May 2002
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0007787
Recognitions & Rankings of J B K Sun Pharma India
Contact details
J B K Sun Pharma India Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3747/Agali No – 2 Kanhiya Nagar Tri Nagar, Delhi, India – 110035
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of J B K Sun Pharma India Private Limited, buy the company report.
Comprehensive company report
J B K Sun Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of J B K Sun Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of J B K Sun Pharma India Private Limited, buy the company report.
Financials of J B K Sun Pharma India Private Limited
FY 2024 filings availableJ B K Sun Pharma India Private Limited reported revenue of ₹15.1 Lakh (down 17% YoY) for FY 2024.
Revenue · FY 2024
₹15.1 Lakh ▼ 17%
Net loss · FY 2024
₹1.71 Lakh margin -11.3%
EBITDA · FY 2024
-₹29,461 margin -2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▲ 72%
5 years · compounded
▲ 34%
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 17% fall in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹29,461 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -11.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of J B K Sun Pharma India Private Limited, buy the company report.
Board of directors of J B K Sun Pharma India Private Limited
J B K Sun Pharma India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Singhal | Director | 13 Jan 2010 | 16 Years 9 Months | Current |
| Meera Rani Singhal | Director | 14 May 2005 | 21 Years 5 Months | Current |
Peer comparison
J B K Sun Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kapco Organic Private Limited | ₹15.15 Lakh (FY 2022) | 128.0% | Agra, Uttar Pradesh, India | |||
| Walia Conschem (Pvt) Ltd | ₹15.14 Lakh (FY 2015) | 3.0% | New Delhi, Delhi, India | |||
| Shivani Organics Private Limited | ₹15.14 Lakh (FY 2025) | -12.0% | Hyderabad, Telangana, India | |||
| Bio Saaa Life Sciences Private Limited | ₹15.13 Lakh (FY 2024) | -12.0% | Varanasi, Uttar Pradesh, India | |||
| Curophil Pharma Private Limited | ₹15.12 Lakh (FY 2020) | Mumbai, Maharashtra, India | ||||
| J B K Sun Pharma India Private Limitedthis company | ₹15.1 Lakh (FY 2024) | -₹1.71 Lakh | -11.3% | -17.0% | Delhi, India | |
| Amruteshwar Pharmaceutical Private Limited | ₹15.1 Lakh (FY 2022) | Akole, Maharashtra, India | ||||
| Edoc Medical Services Private Limited | ₹15.09 Lakh (FY 2025) | 7.0% | Bhubaneswar, Odisha, India | |||
| Synthecis Pharmaceuticals Private Limited | ₹15.07 Lakh (FY 2025) | 854.0% | Hyderabad, Telangana, India | |||
| Vipraj Herbs & Agrifoods Private Limited | ₹15.04 Lakh (FY 2016) | 4.0% | Ahmedabad, Gujarat, India | |||
| Pranam Polyurethane India Private Limited | ₹15.03 Lakh (FY 2025) | -28.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of J B K Sun Pharma India Private Limited, buy the company report.
Auditor
J B K Sun Pharma India Private Limited is audited by JAIN PRIYANKA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN PRIYANKA & CO. | FY 2017 | 015264C |
Shareholding
The shareholding of J B K Sun Pharma India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of J B K Sun Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.05 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Oct 2020 | 100415548 | Hdfc Bank Limited | ₹5.05 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
J B K Sun Pharma India Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (EX.P.) | Filed against the company by Sun Pharmaceutical Industries Ltd. | Pending |
To see the full case history of J B K Sun Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for J B K Sun Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
J B K Sun Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCJ3322Q1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of J B K Sun Pharma India Private Limited, buy the company report.
Recent activity
J B K Sun Pharma India Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Vishal Singhal ceased to be Director on 29 Aug 2010.
AGM
J B K Sun Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
J B K Sun Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.05 Lakh with Charge ID 100415548 was registered on 23 Oct 2020.
Ceased
Vishal Singhal ceased to be Director.
Appointed
Priyanka Singhal was appointed as Director.
Ceased
Satish Kumar ceased to be Director.
Appointed
Meera Rani Singhal was appointed as Director.
Incorporation
14 May 2002
J B K Sun Pharma India Private Limited was registered on 14 May 2002 with Roc Delhi & aged 24 years 5 months as per MCA records.
Frequently asked questions
J B K Sun Pharma India is an active private limited company based in Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 14 May 2002 (24+ years old) and is registered under CIN U24231DL2002PTC115355.
J B K Sun Pharma India has 2 current directors:
- Priyanka Singhal - Director
- Meera Rani Singhal - Director
The latest financial statements of J B K Sun Pharma India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of J B K Sun Pharma India is 09AABCJ3322Q1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of J B K Sun Pharma India is U24231DL2002PTC115355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
J B K Sun Pharma India has 1 court case on record: 1 filed against it. 1 is pending.
J B K Sun Pharma India was incorporated on 14 May 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of J B K Sun Pharma India by revenue are Kapco Organic Private Limited, Walia Conschem (Pvt) Ltd, Shivani Organics Private Limited, Bio Saaa Life Sciences Private Limited, Curophil Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vishal Singhal ceased to be Director on 29 Aug 2010. Priyanka Singhal was appointed as Director on 13 Jan 2010. Satish Kumar ceased to be Director on 13 Jan 2010. J B K Sun Pharma India has 4 board changes on record in total.
Yes, J B K Sun Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0007787).
The registered office of J B K Sun Pharma India is at 3747Agali No – 2 Kanhiya Nagar Tri Nagar, Delhi, India – 110035.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages